William Young, MD
Neurological Surgery · Fort Wayne, INNPI 1982601787
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,174 of the $7,399 with a category attached, or 69.9%. 16 manufacturers reported payments, led by MML US, Inc. at 44.6% of the total. Reporting peaked in 2022 at $4,141 and has fallen 50.3% since, to $2,059 in 2025.
Across 60 payments — averaging $123.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MML US, Inc.$3K
- Insightec,inc$3K
- AbbVie$263
- Pfizer$203
- Medtronic$95
- Johnson & Johnson$45
- plus $205 from 10 others
What the payments were for
- Travel & lodging$5,17470%
- Food & beverage$2,22530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| MML US, Inc. | 10 | $3,302 |
| Insightec,inc | 19 | $3,284 |
| AbbVie(2 entities) | 9 | $263 |
| Pfizer | 4 | $203 |
| Medtronic(2 entities) | 4 | $95 |
| Johnson & Johnson(2 entities) | 3 | $45 |
| AstraZeneca | 2 | $41 |
| Aucta Pharmaceuticals, Inc. | 1 | $24 |
| Aquestive Therapeutics, Inc. | 1 | $21 |
| Portola Pharmaceuticals, LLC | 1 | $20 |
| Adamas Pharmaceuticals, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Biogen | 1 | $18 |
| Servier Pharmaceuticals LLC | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| UCB, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,399 in reported general payments places this provider in the 65th percentile of 112 neurological surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 19 | $273 |
| Cyclobenzaprine Hcl | 13 | $174 |
| Dexamethasone | 29 | $159 |
| Tramadol Hcl | 37 | $65 |
| Famotidine | 26 | $46 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Fort Wayne
- Shahnawaz QureshiFort Wayne$40K
- Jason VoorhiesFort Wayne$8K
- Tyler AtkinsFort Wayne$5K
- Rakesh KhatriFort Wayne$5K
- Stephanie FalatkoFort Wayne$5K
- Kevin VaughtFort Wayne$4K
- Jean-Pierre MobasserCarmel$3.5M
- Troy PaynerCarmel$803K
- Michael TurnerIndianapolis$522K
- Eric PottsCarmel$345K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.